Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

PowderJect and Glaxo Wellcome further expand DNA vaccine alliance

June 24, 1999

Vaccines and vaccine vectors comprising auxotrophic attenuated strains of Listeria

June 18, 1999

Potassium channel-modulating immunosuppressants designed at Merck

June 18, 1999

NIAID sponsors phase III trial of varicella vaccine for prevention of shingles

June 18, 1999

Campylobacter vaccine completes phase II trial

June 17, 1999

Stable immunomodulators related to Imreg-1 developed at BioChem Pharma

June 17, 1999

U.S. patent granted for conjugate vaccine against group B streptococci

June 17, 1999

Aviron completes FluMist bridging study

June 16, 1999

NAVA's novel meningococcal vaccine elicits immunologic memory

June 16, 1999

New PTK inhibitors developed at Bristol-Myers Squibb

June 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026